BlackRock Amends Cogent Biosciences Stake (SC 13G/A)
Ticker: COGT · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 1622229
| Field | Detail |
|---|---|
| Company | Cogent Biosciences, INC. (COGT) |
| Form Type | SC 13G/A |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock updated its stake in Cogent Biosciences, signaling institutional interest.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, disclosing its ownership in Cogent Biosciences, Inc. as of December 31, 2023. This amendment indicates a change in BlackRock's beneficial ownership, which is important for investors as large institutional holdings can influence stock stability and market perception. While the exact percentage change isn't detailed in the provided text, the filing confirms BlackRock's continued significant interest in Cogent Biosciences.
Why It Matters
This filing shows BlackRock's updated position in Cogent Biosciences, signaling their ongoing confidence or a shift in their investment strategy, which can impact investor sentiment.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of institutional ownership and does not inherently present a direct risk to investors.
Analyst Insight
Investors should note BlackRock's continued presence as a significant shareholder, which can provide a degree of stability, but should also investigate the specific percentage of ownership disclosed in the full filing to understand the magnitude of their stake.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Cogent Biosciences, Inc. (company) — the subject company in which BlackRock holds shares
- December 31, 2023 (date) — the date of the event requiring the filing
- January 26, 2024 (date) — the date the SC 13G/A was filed
- 19240Q201 (string) — the CUSIP number for Cogent Biosciences' Common Stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, indicating a change in beneficial ownership by a passive institutional investor.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., a large institutional investment manager.
What company's shares are the subject of this filing?
The shares of Cogent Biosciences, Inc. are the subject of this filing, specifically their Common Stock.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding Cogent Biosciences, Inc. (COGT).